Your session is about to expire
← Back to Search
Educational Program
"Healthy Actions and Lifestyles to Avoid Dementia or Hispanos y el ALTo a la Demencia Program" (HALT-AD Trial)
N/A
Waitlist Available
Led By Sarah Banks, PhD, ABPP-CN
Research Sponsored by Alzheimer's Disease Cooperative Study (ADCS)
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 4 months
Awards & highlights
No Placebo-Only Group
Summary
This trial tests the HALT-AD online program, which teaches people at risk of dementia about healthy habits like good sleep and diet. It offers personalized tips and group support to help them make these changes.
Eligible Conditions
- Dementia
- Alzheimer's Disease
- Brain training
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ 4 months
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~4 months
Treatment Details
Study Objectives
Study objectives can provide a clearer picture of what you can expect from a treatment.Primary study objectives
Users' Engagement With the HALT-AD Online Platform by Measuring the Percentage of Participants Who Completed All Courses.
Users' Engagement With the HALT-AD Online Platform by Measuring the Total Amount of Time (in Minutes) Spent Per User on All Courses Combined
Secondary study objectives
Change From Baseline in Knowledge on the HALT-AD Knowledge Assessment Survey at 4 Months
Change From Baseline in Lifestyle Risk on the HALT-AD Lifestyle Risk Assessment Survey at 4 Months
Change From Baseline in Self-efficacy on the New General Self-Efficacy Scale (NGSE) at 4 Months.
Other study objectives
Acceptability Survey- Users' Acceptability of the HALT-AD Program Content
FOCUS Group Discussion- Qualitative Evaluation of the HALT-AD Program Content
Qualitative Evaluation of Participant Responses During the Focus Group Discussion Groups
+2 moreAwards & Highlights
No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.
Trial Design
1Treatment groups
Experimental Treatment
Group I: HALT-ADExperimental Treatment1 Intervention
HALT-AD is an online educational program designed to teach about dementia and lifestyle changes that can help preserve brain health and lower dementia risk. Participants complete online courses and engage in facilitated discussion groups.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
HALT-AD
2022
N/A
~20
Find a Location
Who is running the clinical trial?
Alzheimer's Disease Cooperative Study (ADCS)Lead Sponsor
24 Previous Clinical Trials
6,411 Total Patients Enrolled
Sarah Banks, PhD, ABPP-CNPrincipal InvestigatorAlzheimer's Disease Cooperative Study (ADCS)
Howard Feldman, MDCM FRCP(C)Study DirectorAlzheimer's Disease Cooperative Study (ADCS)
1 Previous Clinical Trials
296 Total Patients Enrolled